Protein M-based in vivo diagnostic system and detection method
View Patent ↗A wearable device mounted on a living body can detect an analyte response signal transmitted from tissue in the living body. The tissue contains at particles conjugated to at least one complex of (i) an antibody labeled with a fluorophore, the labeled antibody having a target analyte binding site; and (ii) protein M labeled with a quencher that is complimentary to the fluorophore of the labeled antibody, wherein the labeled protein M competes with the target analytes for the target analyte binding site on the labeled antibody; wherein the fluorophore and quencher are spectrally matched such that there is a detectable change in the fluorescent signal. The analyte response signal is related to interaction of the target analytes with the complexes. A processor can determine a presence or absence of the analytes based on the analyte response signal.
1. A composition comprising:
a particle conjugated to a complex comprising
(i) antibodies labeled with a fluorophore, the labeled antibodies having target analyte binding sites; and
(ii) protein M labeled with a quencher that is complimentary to the fluorophore of the labeled antibodies,
wherein the labeled protein M competes with target analytes for the target analyte binding sites on the labeled antibodies;
wherein the fluorophore and quencher are spectrally matched such that there is a detectable change in the fluorescent signal of the labeled antibodies when the fluorophore and the quencher are moved into or out of proximity to each other, and
wherein fluorescent light levels change proportionately in response to the amount of target analytes that are able to bind with the labeled antibodies.
2. The composition of claim 1 , wherein the particle is a nanoparticle.
3. The composition of claim 1 , further comprising a linker to couple the labeled antibodies with labeled protein M.
4. A method comprising:
(a) combining a solution with a nanoparticle conjugated to a complex, the complex comprising
(i) antibodies labeled with a fluorophore, the labeled antibodies having target analyte binding sites; and
(ii) protein M labeled with a quencher that is complimentary to the fluorophore of the labeled antibodies,
wherein the labeled protein M competes with target analytes for the target analyte binding sites on the labeled antibodies;
wherein the fluorophore and quencher are spectrally matched such that there is a detectable change in the fluorescent signal of the labeled antibodies when the fluorophore and the quencher are moved into or out of proximity to each other, and
wherein fluorescent light levels change proportionately in response to the amount of target analytes that are able to bind with the labeled antibodies; and
(b) measuring the fluorescence light level related to a presence of the target analytes in the solution.
5. The method of claim 4 , wherein the particle is a nanoparticle.
6. The method of claim 4 , further comprising a linker to couple the labeled antibodies with the labeled protein M.
7. A method comprising:
introducing particles conjugated to complexes into the living body, the complexes comprising (i) antibodies labeled with a fluorophore, the labeled antibodies having target analyte binding sites; and (ii) protein M labeled with a quencher that is complimentary to the fluorophore of the labeled antibodies,
wherein the labeled protein M competes with target analytes for the target analyte binding sites on the labeled antibodies; wherein the fluorophore and quencher are spectrally matched such that there is a detectable change in the fluorescent signal of the labeled antibodies when the fluorophore and the quencher are moved into or out of proximity to each other; wherein fluorescent light levels change proportionately in response to the amount of target analytes that are able to bind with the labeled antibodies; wherein the complexes are configured to bind with one or more target analytes, wherein presence or absence of the one or more target analytes in the living body is correlated with the biological state of the living body;
detecting, by a wearable device mounted on an external surface of the living body, a signal transmitted from the living body, wherein the signal includes an analyte response signal that is related to binding of the one or more target analytes with the complexes; and
determining a presence or absence of the one or more target analytes based on the analyte response signal.
8. The method of claim 7 , wherein photoexcitation energy is applied by the wearable device.
9. The method of claim 7 , wherein the labeled antibodies are further labeled with a nanoparticle.
10. The method of claim 7 , further comprising a linker to couple the labeled antibodies with labeled protein M.